In high-TMB Bladder Urothelial Carcinoma (BLCA) samples, lower YTHDC2’s expression level was also significantly linked to lower overall survival rate (Supplementary Fig. S1B). This evidence concerns the gene YTHDC2 and bladder transitional cell carcinoma.